Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BioDelivery Sciences International Inc

+ Add to Watchlist

BD5:GR

7.207 EUR 0.263 3.52%

As of 15:43:07 ET on 05/22/2015.

Snapshot for BioDelivery Sciences International Inc (BD5)

Open: 7.546 Day's Range: 7.086 - 7.618 Volume: 79
Previous Close: 7.470 52wk Range: 6.336 - 14.500 1-Yr Rtn: +13.07%

Stock Chart for BD5

No chart data available.
  • BD5:GR 7.282
  • 1D
  • 1M
  • 1Y
7.470
Interactive BD5 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BD5

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -0.4520
Est. PEG Ratio -
Market Cap (M EUR) 377.67
Shares Outstanding (M) 52.40
30 Day Average Volume 176
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BD5

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BD5

BioDelivery Sciences International, Inc. is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology. The Company's technology is designed for a broad base of pharmaceuticals, vaccines, and over-the-counter drugs. Biodelivery's technology encapsulates the selected drug in a cochleate cylinder.

Francis E O'Donnell JrChairmanMark A SirgoPresident/CEO
Ernie R De PaolantonioCFO/Secretary/TreasurerAndrew L FinnExec VP:Product Development
More Company Profile & Key Executives for BD5

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil